Related Experiment Videos
[Tuberculosis complicated with liver cirrhosis]
Akira Saito1, Naohiro Nagayama, Osamitsu Yagi
1Department of Respiratory Disease, National Hospital Organization Tokyo National Hospital. asaitou-tky@umin.ac.jp
Kekkaku : [Tuberculosis]
|August 17, 2006
Summary
Tuberculous patients with liver cirrhosis face higher mortality and adverse drug reactions. Combination chemotherapy is tolerable with careful monitoring for side effects in these patients.
Area of Science:
- Hepatology
- Infectious Diseases
- Pulmonology
Context:
- Liver cirrhosis is a significant comorbidity in patients with tuberculosis.
- Understanding the clinical profile of these patients is crucial for effective management.
Purpose:
- To investigate the clinical characteristics of tuberculosis patients with coexisting liver cirrhosis.
- To assess the outcomes and treatment challenges in this specific patient group.
Summary:
- This study analyzed 44 tuberculosis patients with liver cirrhosis, identifying Hepatitis C and alcohol as primary causes of cirrhosis.
- High mortality (39%) was observed, with liver failure as the leading cause of death.
- Multi-drug chemotherapy for tuberculosis resulted in frequent adverse effects (leukopenia, thrombocytopenia), manageable with regimen adjustments.
Impact:
- Highlights the increased risks associated with tuberculosis in cirrhotic patients.
- Demonstrates the potential tolerability of multi-drug chemotherapy in patients with liver dysfunction, emphasizing the need for vigilant side-effect monitoring.